(Q51817061)

English

Melanoma following treatment with alemtuzumab for multiple sclerosis.

scientific article published in April 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

title

Melanoma following treatment with alemtuzumab for multiple sclerosis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

0 references

A A Pace

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

J P Zajicek

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

published in

European Journal of Neurology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

volume

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

page(s)

e70-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

cites work

Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02552.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1468-1331.2009.02552.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

PubMed publication ID

19222552

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19222552

retrieved

13 April 2018

reference URL

http://europepmc.org/abstract/MED/19222552

ResearchGate publication ID

24020556

0 references

(Q51817061)

Melanoma following treatment with alemtuzumab for multiple sclerosis.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)